releases: https://mcbath.house.gov/press-releases?ID=465635B8-8346-4EB0-85E2-E7F72050574B
Data license: MIT · Data source: dwillis/congress-press
This data as json
| url | title | date | year | month | party | chamber | state | member_name | bioguide_id | domain | scraper | source | date_source | text | has_text | collected_at | updated_at |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| https://mcbath.house.gov/press-releases?ID=465635B8-8346-4EB0-85E2-E7F72050574B | Rep. McBath Statement on Latest Efforts to Cap Out-of-Pocket Costs of Insulin | 2022-07-29 | 2022 | 2022-07 | Democrat | House | GA | Lucy McBath | M001208 | mcbath.house.gov | mcbath | https://mcbath.house.gov/press-releases | scraper | Washington, DC — Today, Rep. Lucy McBath (D-GA) released a statement following reporting that her legislation on a $35 insulin out-of-pocket cost cap would be added to the text of the Inflation Reduction Act. McBath’s bill is a companion measure to the one introduced by Georgia Senator Reverend Raphael Warnock (D-GA) in the Senate. “Families cannot afford for Washington to play politics with the health and the lives of diabetic patients—we must carve a path forward and get this done for the American people,” McBath said. “This is a common sense, bipartisan piece of legislation that would significantly improve access and affordability for insulin users, many of whom have had to ration or skip doses for decades. I’m pleased that my bill to cap insulin costs at $35 a month is being added to robust legislation that will strengthen health care access and lower rising costs for Georgians. Along with Senator Warnock, I look forward to continuing the work to make prescription drugs more affordable for American families.” | 1 | 2026-03-30T01:40:41Z | 2026-04-08T02:49:02Z |